Treatment with long-acting lanreotide autogel in early infancy in patients with severe neonatal hyperinsulinism

Abstract Background Treatment of severe diffuse congenital hyperinsulinism (CHI) without sufficient response to diazoxide is complicated by the lack of approved drugs. Therefore, patients are often hospitalized long-term or have to undergo pancreatic surgery if episodes of severe hypoglycaemia canno...

Description complète

Détails bibliographiques

Auteurs principaux:	Heike Corda, Sebastian Kummer, Alena Welters, Norbert Teig, Dirk Klee, Ertan Mayatepek, Thomas Meissner
Format:	Artigo
Langue:	Inglês
Publié:	BMC 2017-06-01
Collection:	Orphanet Journal of Rare Diseases
Sujets:	Congenital hyperinsulinism Beckwith-Wiedemann syndrome Hyperinsulinaemic hypoglycaemia Somatostatin analogue Adverse event
Accès en ligne:	http://link.springer.com/article/10.1186/s13023-017-0653-x
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!